
Medtronic (MDT) Stock Forecast & Price Target
Medtronic (MDT) Analyst Ratings
Bulls say
Medtronic is a strong and diversified company in the medical technology sector with a successful M&A strategy, a target price of $74, strong revenue growth, and plans for continued growth through new product launches and strategic acquisitions. While there are some potential risks, the company is well-positioned to weather challenges such as competition, global volatility, and supply chain disruptions, and has a track record of returning cash to shareholders through dividends and share purchases.
Bears say
Medtronic is facing risks to its EPS growth and ROIC if capital is not allocated wisely and there are slow product growth and competition in the global market. Recent investments in the cardiovascular and medical surgical industries could bring potential growth opportunities, but there are also potential risks from macroeconomic factors and global economic challenges. Despite these challenges, Medtronic remains a leader in the MedTech industry with a diverse workforce and strong potential for growth in US sales and various growth drivers.
This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.
Medtronic (MDT) Analyst Forecast & Price Prediction
Start investing in Medtronic (MDT)
Order type
Buy in
Order amount
Est. shares
0 shares